Long-Term Patient Experience: Communication Breakdowns and Labeling Concerns.
I joined IVUSE in June 2025 and remained a patient for nearly a year because I genuinely believed I was receiving structured medical care. I wanted it to work, and for a long time, I gave them the benefit of the doubt.
Early communication gaps felt manageable. If a promised follow-up didn’t arrive, I assumed it was a busy clinic. If an email went unanswered, I followed up. I had several consultations with Gabby, and I liked her. She was calm, seemed knowledgeable, and reassuring. That personal connection is largely why I stayed.
But the operational side never matched the clinical tone. Emails often required multiple reminders. Scheduled phone consultations did not always happen at the agreed time. When Gabby didn’t call, explanations followed — different ones on different occasions. This happened more than once. Over time, that inconsistency stopped feeling incidental and started feeling systemic.
The real turning point came with AOD-9604. I was prescribed it under the understanding that clinician approval was required prior to shipment. Later, during a consultation, it became clear that Gabby, my assigned clinician, had not been aware of it until we discussed it. She advised me to stop immediately.
When I examined the vial more closely, I realized it had no pharmacy prescription label, no patient name, and no dispensing pharmacy information. It was marked "Research Use Only.” That wording is not minor. Realizing I had injected something labeled that way under the assumption of clinical oversight was deeply concerning.
In hindsight, I also recognized that none of the medications I had received — including Tirzepatide — ever arrived with patient-specific pharmacy labeling. At the time, I trusted the process. Now I understand how significant that omission is.
Even basic prescriptions have not been handled reliably. I placed an order for Zofran ODT on May 18 and, to this day, have received no shipping confirmation, no tracking information, and no meaningful update. My follow-up emails about this order have gone unanswered. I am left not even knowing whether the medication will be shipped at all.
After nearly a year, the pattern became clear: communication required chasing, scheduled calls were unreliable, documentation was incomplete, and serious questions were left unresolved.
Healthcare requires transparency, proper labeling, and accountable oversight — especially when injectable products are involved. My experience did not reflect those standards.
I stayed because I believed in the care. I left because I realized I could no longer rely on it.
